Companies: 10,795·Total market cap: $144.5T
Acurx Pharmaceuticals, Inc.

Acurx Pharmaceuticals, Inc.

ACXPNASDAQHealthcare● Active
$1.65
+$0.03(+2.07%)
Market Cap$2620920
P/E Ratio
52W High$21
52W Low$1.326
Overview

Acurx Pharmaceuticals, Inc. (ACXP) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

ACXP · net income · updated Jun 9, 2026

Core profitability metrics

Net income was −$8.0M for FY2025 (fiscal year ending 2025-12-31), up 43.5% year-over-year. Net profit margin was —.

FY2025 Net Income−$8.0M▲ +43.5% YoY
Trailing 12M (TTM)−$7.5Mtrailing 4 quarters sum
Net Profit Margin
YoY Change+43.5%
5-Year CAGRN/AN/A — contains loss years
FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0
Source: FMP /income-statement · US GAAP · USDUpdated: Jun 9, 2026

Annual net income history

Net IncomeNet LossNet Margin %

▸ FMP /income-statement · Annual · ACXP net income history · ACXP profit margin

Annual net income data

Fiscal YearNet IncomeYoY ChangeNet Margin
FY2025Loss−$8.0M▲ +43.5%
FY2024Loss−$14.1M▲ +3.3%
FY2023Loss−$14.6M▼ 20.5%
FY2022Loss−$12.1M▲ +5.1%
FY2021Loss−$12.7M▼ 177.1%

Net income vs peers (Healthcare)

#CompanyNet IncomeYoY
#1
Acurx Pharmaceuticals, Inc.
Acurx Pharmaceuticals, Inc.YOU
ACXP
−$8.0M+43.5%
#2
Johnson & Johnson
Johnson & Johnson
JNJ
$26.80B+90.6%
#3
Eli Lilly and Company
Eli Lilly and Company
LLY
$20.64B+94.9%
#4
UnitedHealth Group Incorporated
UnitedHealth Group Incorporated
UNH
$12.06B-16.3%
#5
AbbVie Inc.
AbbVie Inc.
ABBV
$4.23B-1.2%
Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

Acurx Pharmaceuticals, Inc. (ACXP) reported net income of −$8.0M for FY2025 (fiscal year ending 2025-12-31), up 43.5% year-over-year. The net profit margin was — — meaning the company kept $— of every dollar of revenue as profit.

Acurx Pharmaceuticals, Inc. has not yet achieved annual profitability based on available data (7 fiscal years). The company has reported net losses across all available periods.

Acurx Pharmaceuticals, Inc.'s net profit margin was — for FY2025, based on the latest annual results.

Investors sometimes search for "Acurx Pharmaceuticals, Inc. net worth" — the company's market capitalization is a separate figure from ACXP net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Frequently asked questions

ACXP net income · 4 questions

Acurx Pharmaceuticals, Inc. is not currently profitable on an annual basis. The company reported a net loss of $8.0M for FY2025.

is ACXP profitabledoes ACXP make a profitACXP profitabilityACXP profitable company

Source: FMP /income-statement · GAAP · Acurx Pharmaceuticals, Inc. · Acurx Pharmaceuticals, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 9, 2026